Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor γ activation has coordinate effects on gene expression in multiple insulin-sensitive tissues

Endocrinology

Volumn 142, Issue 3, 2001, Pages 1269-1277

  Way, James M ^a   Harrington, W Wallace ^a   Brown, Kathleen K ^a   Gottschalk, William K ^a   Sundseth, Scott S ^a   Mansfield, Traci A ^b   Ramachandran, Ravi K ^b   Willson, Timothy M ^a   Kliewer, Steven A ^a  

^a GLAXOSMITHKLINE   (United States)

^b CURAGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; LIPID; MESSENGER RNA; N (2 BENZOYLPHENYL) O [2 (METHYL 2 PYRIDINYLAMINO)ETHYL]TYROSINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROWN ADIPOSE TISSUE; DIABETES MELLITUS; EPIDIDYMIS; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; GENE CONTROL; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPOGENESIS; LIVER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RAT STRAIN; RNA ANALYSIS; SOLEUS MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL; UNINDEXED SEQUENCE; WHITE ADIPOSE TISSUE;

EID: 0035091701     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.3.8037     Document Type: Article

References (48)

1. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor
2. The PPARs: From orphan receptors to drug discovery
3. Thiazolidinediones for type 2 diabetes
4. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
5. Orphan nuclear receptors: Shifting endocrinology into reverse
6. N-(2-Benzoylphenyl)-L-tyrosine PPARγ agonists. I. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents
7. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-γ reverses the diabetic phenotype of the Zucker diabetic fatty rat
8. Monotherapy with G1262570, a tyrosine-based non-thiazolidinedione PPARγ agonist, improves metabolic control in type 2 diabetes mellitus patients
9. PPARγ an essential regulator of adipogenesis and modulator of fat cell function
10. PPARγ, the ultimate thrifty gene
11. Gene expression analysis by transcript profiling coupled to a gene database query
12. Real time quantitative PCR
13. A novel method for real time quantitative RT-PCR
14. PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene
15. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARα and PPARγ activators
16. PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
17. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
18. Increased adipose expression of the uncoupling protein-3 gene by thiazolidinediones in Wistar fatty rats and in cultured adipocytes
19. Uncoupling proteins 2 and 3: Potential regulators of mitochondrial energy metabolism
20. Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean
21. mPPARγ2: Tissue-specific regulator of an adipocyte enhancer
22. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
23. Analysis of the tissue-specific expression, developmental regulation, and linkage relationships of a rodent gene encoding heart fatty acid binding protein
24. Transcriptional regulation of adipogenesis
25. ADD-1 provides major new insight into the mechanism of insulin action
26. Novel delayed-early and highly insulin-induced growth response genes. Identification of HRS, a potential regulator of alternative pre-mRNA splicing
27. Coexpression of liver-specific and growth-induced genes in perinatal and regenerating liver: Attainment and maintenance of the differentiated state during rapid proliferation
28. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-LI adipocytes
29. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ
30. Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance
31. Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism
32. Insulin sensitization in diabetic rat liver by an antihyperglycemic agent
33. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects
34. Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and C57BL/KsJ-db/db mice
35. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats
36. Effects of troglitazone on substrate storage and utilization in insulin-resistant rats
37. In vivo effects of pioglitazone on uncoupling protein-2 and -3 mRNA levels in skeletal muscle of hyperglycemic KK mice
38. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes
39. Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα
40. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes revolve up-regulation of peroxisome proliferator-activated receptor-γ
41. Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years
42. Insulin downregulates pyruvate dehydrogenase kinase (PDK) mRNA: Potential mechanism contributing to increased lipid oxidation in insulin-resistant subjects
43. Tissue-specific actions of antidiabetic thiazolidinediones on the reduced fatty acid oxidation in skeletal muscle and liver of Zucker diabetic fatty rats
44. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin
45. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARγ agonist) action
46. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: Relation to insulin action
47. Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects
48. Troglitazone action is independent of adipose tissue